From memory, the 5% non response was attributed to it being a lower dose - suggesting that the response can be dose dependant.
- Forums
- ASX - By Stock
- HSV -2
From memory, the 5% non response was attributed to it being a...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$14.80 |
Change
0.550(3.86%) |
Mkt cap ! $318.1M |
Open | High | Low | Value | Volume |
$15.00 | $15.23 | $14.05 | $190.2K | 12.95K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 200 | $14.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.06 | 1 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 170 | 14.500 |
1 | 35 | 14.490 |
1 | 118 | 14.410 |
1 | 248 | 14.400 |
1 | 38 | 14.260 |
Price($) | Vol. | No. |
---|---|---|
15.020 | 724 | 3 |
15.030 | 125 | 1 |
15.090 | 130 | 1 |
15.140 | 96 | 1 |
15.150 | 500 | 1 |
Last trade - 15.59pm 13/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online